Global Prophylactic Human Vaccines Market Research Report 2016

August 2016 | 113 pages | ID: G640ADB9079EN
QYResearch

Abstracts

Notes:

Production, means the output of Prophylactic Human Vaccines

Revenue, means the sales value of Prophylactic Human Vaccines

This report studies Prophylactic Human Vaccines in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• ALK - Abello A/S (Denmark)
• Altimmune, Inc. (US)
• Bavarian Nordic A/S (Denmark)
• BiondVax Pharmaceuticals Ltd. (Israel)
• Bharat Biotech International Limited (India)
• GlaxoSmithKline Plc. (UK)
• Hualan Biological Engineering Inc. (China)
• Janssen Pharmaceuticals, Inc. (US)
• MedImmune (US)
• Merck & Co., Inc. (US)
• Pfizer Inc. (US)
• Sanofi Pasteur SA (France)
• Serum Institute of India Pvt. Ltd. (India)
• Shanghai BravoBio Co., Ltd. (China)
• Seqirus (UK)
• SK Chemicals Co., Ltd. (Korea)
• Takeda Pharmaceutical Company Limited (Japan)
• Zydus Cadila (India)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Prophylactic Human Vaccines in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Prophylactic Human Vaccines in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Prophylactic Human Vaccines Market Research Report 2016

1 PROPHYLACTIC HUMAN VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of Prophylactic Human Vaccines
1.2 Prophylactic Human Vaccines Segment by Type
  1.2.1 Global Production Market Share of Prophylactic Human Vaccines by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Prophylactic Human Vaccines Segment by Application
  1.3.1 Prophylactic Human Vaccines Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Prophylactic Human Vaccines Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Prophylactic Human Vaccines (2011-2021)

2 GLOBAL PROPHYLACTIC HUMAN VACCINES MARKET COMPETITION BY MANUFACTURERS

2.1 Global Prophylactic Human Vaccines Production and Share by Manufacturers (2015 and 2016)
2.2 Global Prophylactic Human Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Prophylactic Human Vaccines Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Prophylactic Human Vaccines Manufacturing Base Distribution, Sales Area and Product Type
2.5 Prophylactic Human Vaccines Market Competitive Situation and Trends
  2.5.1 Prophylactic Human Vaccines Market Concentration Rate
  2.5.2 Prophylactic Human Vaccines Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL PROPHYLACTIC HUMAN VACCINES PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Prophylactic Human Vaccines Production and Market Share by Region (2011-2016)
3.2 Global Prophylactic Human Vaccines Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL PROPHYLACTIC HUMAN VACCINES SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Prophylactic Human Vaccines Consumption by Regions (2011-2016)
4.2 North America Prophylactic Human Vaccines Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Prophylactic Human Vaccines Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Prophylactic Human Vaccines Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Prophylactic Human Vaccines Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Prophylactic Human Vaccines Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Prophylactic Human Vaccines Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL PROPHYLACTIC HUMAN VACCINES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Prophylactic Human Vaccines Production and Market Share by Type (2011-2016)
5.2 Global Prophylactic Human Vaccines Revenue and Market Share by Type (2011-2016)
5.3 Global Prophylactic Human Vaccines Price by Type (2011-2016)
5.4 Global Prophylactic Human Vaccines Production Growth by Type (2011-2016)

6 GLOBAL PROPHYLACTIC HUMAN VACCINES MARKET ANALYSIS BY APPLICATION

6.1 Global Prophylactic Human Vaccines Consumption and Market Share by Application (2011-2016)
6.2 Global Prophylactic Human Vaccines Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL PROPHYLACTIC HUMAN VACCINES MANUFACTURERS PROFILES/ANALYSIS

7.1 ALK - Abello A/S (Denmark)
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Prophylactic Human Vaccines Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 ALK - Abello A/S (Denmark) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Altimmune, Inc. (US)
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Prophylactic Human Vaccines Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Altimmune, Inc. (US) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Bavarian Nordic A/S (Denmark)
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Prophylactic Human Vaccines Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Bavarian Nordic A/S (Denmark) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 BiondVax Pharmaceuticals Ltd. (Israel)
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Prophylactic Human Vaccines Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 BiondVax Pharmaceuticals Ltd. (Israel) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Bharat Biotech International Limited (India)
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Prophylactic Human Vaccines Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Bharat Biotech International Limited (India) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 GlaxoSmithKline Plc. (UK)
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Prophylactic Human Vaccines Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 GlaxoSmithKline Plc. (UK) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Hualan Biological Engineering Inc. (China)
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Prophylactic Human Vaccines Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Hualan Biological Engineering Inc. (China) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Janssen Pharmaceuticals, Inc. (US)
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Prophylactic Human Vaccines Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Janssen Pharmaceuticals, Inc. (US) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 MedImmune (US)
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Prophylactic Human Vaccines Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 MedImmune (US) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Merck & Co., Inc. (US)
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Prophylactic Human Vaccines Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Merck & Co., Inc. (US) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Pfizer Inc. (US)
7.12 Sanofi Pasteur SA (France)
7.13 Serum Institute of India Pvt. Ltd. (India)
7.14 Shanghai BravoBio Co., Ltd. (China)
7.15 Seqirus (UK)
7.16 SK Chemicals Co., Ltd. (Korea)
7.17 Takeda Pharmaceutical Company Limited (Japan)
7.18 Zydus Cadila (India)

8 PROPHYLACTIC HUMAN VACCINES MANUFACTURING COST ANALYSIS

8.1 Prophylactic Human Vaccines Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Prophylactic Human Vaccines

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Prophylactic Human Vaccines Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Prophylactic Human Vaccines Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL PROPHYLACTIC HUMAN VACCINES MARKET FORECAST (2016-2021)

12.1 Global Prophylactic Human Vaccines Production, Revenue Forecast (2016-2021)
12.2 Global Prophylactic Human Vaccines Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Prophylactic Human Vaccines Production Forecast by Type (2016-2021)
12.4 Global Prophylactic Human Vaccines Consumption Forecast by Application (2016-2021)
12.5 Prophylactic Human Vaccines Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prophylactic Human Vaccines
Figure Global Production Market Share of Prophylactic Human Vaccines by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Prophylactic Human Vaccines Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Prophylactic Human Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Prophylactic Human Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Prophylactic Human Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Prophylactic Human Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Prophylactic Human Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Prophylactic Human Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Prophylactic Human Vaccines Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Prophylactic Human Vaccines Production of Key Manufacturers (2015 and 2016)
Table Global Prophylactic Human Vaccines Production Share by Manufacturers (2015 and 2016)
Figure 2015 Prophylactic Human Vaccines Production Share by Manufacturers
Figure 2016 Prophylactic Human Vaccines Production Share by Manufacturers
Table Global Prophylactic Human Vaccines Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Prophylactic Human Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Prophylactic Human Vaccines Revenue Share by Manufacturers
Table 2016 Global Prophylactic Human Vaccines Revenue Share by Manufacturers
Table Global Market Prophylactic Human Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Prophylactic Human Vaccines Average Price of Key Manufacturers in 2015
Table Manufacturers Prophylactic Human Vaccines Manufacturing Base Distribution and Sales Area
Table Manufacturers Prophylactic Human Vaccines Product Type
Figure Prophylactic Human Vaccines Market Share of Top 3 Manufacturers
Figure Prophylactic Human Vaccines Market Share of Top 5 Manufacturers
Table Global Prophylactic Human Vaccines Production by Regions (2011-2016)
Figure Global Prophylactic Human Vaccines Production and Market Share by Regions (2011-2016)
Figure Global Prophylactic Human Vaccines Production Market Share by Regions (2011-2016)
Figure 2015 Global Prophylactic Human Vaccines Production Market Share by Regions
Table Global Prophylactic Human Vaccines Revenue by Regions (2011-2016)
Table Global Prophylactic Human Vaccines Revenue Market Share by Regions (2011-2016)
Table 2015 Global Prophylactic Human Vaccines Revenue Market Share by Regions
Table Global Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table China Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table India Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Prophylactic Human Vaccines Consumption Market by Regions (2011-2016)
Table Global Prophylactic Human Vaccines Consumption Market Share by Regions (2011-2016)
Figure Global Prophylactic Human Vaccines Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Prophylactic Human Vaccines Consumption Market Share by Regions
Table North America Prophylactic Human Vaccines Production, Consumption, Import & Export (2011-2016)
Table Europe Prophylactic Human Vaccines Production, Consumption, Import & Export (2011-2016)
Table China Prophylactic Human Vaccines Production, Consumption, Import & Export (2011-2016)
Table Japan Prophylactic Human Vaccines Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Prophylactic Human Vaccines Production, Consumption, Import & Export (2011-2016)
Table India Prophylactic Human Vaccines Production, Consumption, Import & Export (2011-2016)
Table Global Prophylactic Human Vaccines Production by Type (2011-2016)
Table Global Prophylactic Human Vaccines Production Share by Type (2011-2016)
Figure Production Market Share of Prophylactic Human Vaccines by Type (2011-2016)
Figure 2015 Production Market Share of Prophylactic Human Vaccines by Type
Table Global Prophylactic Human Vaccines Revenue by Type (2011-2016)
Table Global Prophylactic Human Vaccines Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Prophylactic Human Vaccines by Type (2011-2016)
Figure 2015 Revenue Market Share of Prophylactic Human Vaccines by Type
Table Global Prophylactic Human Vaccines Price by Type (2011-2016)
Figure Global Prophylactic Human Vaccines Production Growth by Type (2011-2016)
Table Global Prophylactic Human Vaccines Consumption by Application (2011-2016)
Table Global Prophylactic Human Vaccines Consumption Market Share by Application (2011-2016)
Figure Global Prophylactic Human Vaccines Consumption Market Share by Application in 2015
Table Global Prophylactic Human Vaccines Consumption Growth Rate by Application (2011-2016)
Figure Global Prophylactic Human Vaccines Consumption Growth Rate by Application (2011-2016)
Table ALK - Abello A/S (Denmark) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ALK - Abello A/S (Denmark) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure ALK - Abello A/S (Denmark) Prophylactic Human Vaccines Market Share (2011-2016)
Table Altimmune, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Altimmune, Inc. (US) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Altimmune, Inc. (US) Prophylactic Human Vaccines Market Share (2011-2016)
Table Bavarian Nordic A/S (Denmark) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bavarian Nordic A/S (Denmark) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bavarian Nordic A/S (Denmark) Prophylactic Human Vaccines Market Share (2011-2016)
Table BiondVax Pharmaceuticals Ltd. (Israel) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BiondVax Pharmaceuticals Ltd. (Israel) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure BiondVax Pharmaceuticals Ltd. (Israel) Prophylactic Human Vaccines Market Share (2011-2016)
Table Bharat Biotech International Limited (India) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bharat Biotech International Limited (India) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bharat Biotech International Limited (India) Prophylactic Human Vaccines Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Plc. (UK) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc. (UK) Prophylactic Human Vaccines Market Share (2011-2016)
Table Hualan Biological Engineering Inc. (China) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hualan Biological Engineering Inc. (China) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Hualan Biological Engineering Inc. (China) Prophylactic Human Vaccines Market Share (2011-2016)
Table Janssen Pharmaceuticals, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Janssen Pharmaceuticals, Inc. (US) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Janssen Pharmaceuticals, Inc. (US) Prophylactic Human Vaccines Market Share (2011-2016)
Table MedImmune (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MedImmune (US) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure MedImmune (US) Prophylactic Human Vaccines Market Share (2011-2016)
Table Merck & Co., Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co., Inc. (US) Prophylactic Human Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co., Inc. (US) Prophylactic Human Vaccines Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prophylactic Human Vaccines
Figure Manufacturing Process Analysis of Prophylactic Human Vaccines
Figure Prophylactic Human Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Prophylactic Human Vaccines Major Manufacturers in 2015
Table Major Buyers of Prophylactic Human Vaccines
Table Distributors/Traders List
Figure Global Prophylactic Human Vaccines Production and Growth Rate Forecast (2016-2021)
Figure Global Prophylactic Human Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table Global Prophylactic Human Vaccines Production Forecast by Regions (2016-2021)
Table Global Prophylactic Human Vaccines Consumption Forecast by Regions (2016-2021)
Table Global Prophylactic Human Vaccines Production Forecast by Type (2016-2021)
Table Global Prophylactic Human Vaccines Consumption Forecast by Application (2016-2021)